EssilorLuxottica SA (EL) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

379.7 k

Shareholding (Dec 2023)

FII

0.06%

Held by 9 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Strong Long Term Fundamental Strength with a 392.90% CAGR growth in Net Sales

Company has a low Debt to Equity ratio (avg) at times

With ROE of 0.00%, it has a Attractive valuation with a 3.37 Price to Book Value

Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 142,371 Million ()

P/E

Industry P/E

Dividend Yield

20.97%

Debt Equity

0.23

Return on Equity

0.00%

Price to Book

3.76

Revenue and Profits:

Net Sales:

708 Million

(Quarterly Results - Dec 2007)

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

6.57%

6 Months

14.35%

1 Year

22.02%

2 Years

53.68%

3 Years

55.3%

4 Years

52.37%

5 Years

120.05%

EssilorLuxottica SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

392.90%

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

422.21

Net Debt to Equity (avg)

0.20

Sales to Capital Employed (avg)

0.06

Tax Ratio

Dividend Payout Ratio

76.01%

Pledged Shares

Institutional Holding

0.01%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.37

EV to EBIT

EV to EBITDA

EV to Capital Employed

2.93

EV to Sales

46.84

PEG Ratio

Dividend Yield

23.42%

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 9 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'07 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2007 is 6.10% vs 7.39% in Dec 2006",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2007 is 0.00% vs 0.00% in Dec 2006",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'07",
        "Dec'06",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "708.00",
          "val2": "667.30",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 3.68% vs 23.58% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 6.36% vs 41.41% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25,395.00",
          "val2": "24,494.00",
          "chgp": "3.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,243.00",
          "val2": "6,179.00",
          "chgp": "1.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "198.00",
          "val2": "156.00",
          "chgp": "26.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-128.00",
          "val2": "-109.00",
          "chgp": "-17.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,426.00",
          "val2": "2,281.00",
          "chgp": "6.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "129.80%",
          "val2": "133.00%",
          "chgp": "-0.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'07 - YoY

Dec'07

Dec'06

Change(%)

Net Sales

708.00

667.30

6.10%

Operating Profit (PBDIT) excl Other Income

0.00

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

0.00

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2007 is 6.10% vs 7.39% in Dec 2006

Consolidated Net Profit

YoY Growth in quarter ended Dec 2007 is 0.00% vs 0.00% in Dec 2006

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

25,395.00

24,494.00

3.68%

Operating Profit (PBDIT) excl Other Income

6,243.00

6,179.00

1.04%

Interest

198.00

156.00

26.92%

Exceptional Items

-128.00

-109.00

-17.43%

Consolidate Net Profit

2,426.00

2,281.00

6.36%

Operating Profit Margin (Excl OI)

129.80%

133.00%

-0.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 3.68% vs 23.58% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 6.36% vs 41.41% in Dec 2022

All Annual Results

Company CV

About EssilorLuxottica SA

EssilorLuxottica SA

Pharmaceuticals & Biotechnology

EssilorLuxottica SA, formerly known as Essilor International Compagnie Generale D Optique SA, is a France-based ophthalmic company. The Company designs, manufactures and markets a range of lenses, frames and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. The Company operates under a number of brands, including Ray-Ban, Oakley and Varilux, among others. The Company operates in Europe, North America, Asia Pacific, the Middle East, Africa and Latin America.

Company Coordinates

Company Details

147 rue de Paris , CHARENTON-LE-PONT None : 94220

Tel: 33 1 49774224

https://www.essilorluxottica.com/

Registrar Details